GlassScriptPhysician profile
Callie G Williams
NPI 1508275298
$825.24
in general payments reported to CMS, 2019-2025
17 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.99 · 2022: $243 · 2023: $264 · 2024: $125 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $176.48 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $122.51 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $101.86 | 2022-2023 | Verquvo |
| Astellas Pharma US INC | $52.99 | 2021 | |
| Amgen INC. | $47.91 | 2022-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $44.26 | 2022-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $42.83 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.80 | 2023-2025 | Jardiance |
| Pfizer INC. | $36.53 | 2025 | |
| Lantheus Medical Imaging, INC. | $35.33 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.78 | 2024 | Relistor |
| Novartis Pharmaceuticals Corporation | $22.46 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.86 | 2024 | Arcalyst |
| Silk Road Medical, INC. | $17.09 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Novo Nordisk INC | $14.46 | 2025 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.34 | 2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $13.75 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.